
Sarepta
Biopharmaceutical company focused on developing RNA-targeted therapies for rare genetic diseases.
About
Sarepta Therapeutics is a biopharmaceutical company dedicated to discovering, developing, and commercializing RNA-targeted therapeutics for patients with rare genetic diseases. Their primary focus is on Duchenne muscular dystrophy (DMD), a devastating and life-limiting genetic disorder. Sarepta's innovative approach utilizes various RNA-based technologies to address the underlying genetic causes of these diseases.
Key facts
At-a-glance profile data
- Website
- sarepta.com
- Headquarters
- Cambridge, United States
- Employees
- 1,162
- Total funding
- -
- Business model
- B2B
Tech stack
Detected on sarepta.com and in its job posts, last scanned 1 Sept 2026. Run your own scan
- Frontend
- jQuery
- Backend
- Python
- CDN
- Cloudflare
- Hosting
- AWS, Google Cloud
- Email provider
- Mimecast
- Email marketing
- Mailgun
- Hiring platform
- Workday
- Video / media
- Vimeo
Add first review
Frequently asked
How many employees does Sarepta have?
Sarepta has approximately 1,162 people on record.
